Prospeo
Hero Section BackgroundHero Section Background
KeyBio

KeyBio Revenue

Biotechnology ResearchFlag of USCambridge, Massachusetts, United States1-10 Employees

$

KeyBio revenue & valuation

Annual revenue$85,555
Revenue per employee$86,000
Estimated valuation?$273,776
Total fundingNo funding

Key Contact at KeyBio

Flag of US

Layne Sadler

Founder – Bioinformatics & Molecular Oncology

Company overview

Headquarters77 Massachusetts Ave, Cambridge, MA 02139, US
Website
NAICS541714
Keywords
Research, Oncology, Drug Discovery, Bioinformatics, Diagnostics, Artificial Intelligence, Deep Learning, Machine Learning, Therapeutics, Genetics, Cancer, ai, Genomics, Gene Therapy
Employees1-10

KeyBio Email Formats

KeyBio uses 1 email format. The most common is {first name} (e.g., john@key.bio), used 100% of the time.

FormatExamplePercentage
{first name}
john@key.bio
100%

About KeyBio

KeyBio’s technology platform discovers immuno-oncology drug targets in the tumor microenvironment by identifying germline genomic mutations that drive survival in cancer patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

KeyBio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

KeyBio has never raised funding before.

Frequently asked questions

KeyBio is located in Cambridge, Massachusetts, US.
KeyBio generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
KeyBio has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
KeyBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles